mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0005 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.0006 |
mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0008 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |